Clinical trial
Randomized Trial to Prevent Vascular Events in HIV - REPRIEVE
NCT02344290 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Trial to Prevent Vascular Events in HIV - REPRIEVE
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 26, 2015
- Completion date
- August 21, 2023
- Enrollment
- 7,769 (actual)
- Sites
- 137
Conditions
As the registry lists them; a condition with its own page is linked.